Codes / ICD10CM / E10.52

E10.52 Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene (E10.52)
  • Also known as: T1DM with peripheral vascular disease and gangrene, Type 1 diabetes with gangrenous peripheral angiopathy.

Summary

Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene is a chronic condition where insufficient insulin production leads to high blood sugar levels, which over time damages the blood vessels in the extremities. This damage impairs blood flow to the legs, feet, or hands, resulting in tissue death (gangrene) due to severe ischemia and necrosis.

Causes

The primary cause is long-term uncontrolled hyperglycemia from type 1 diabetes, which damages the small and large blood vessels in the peripheral circulation. This vascular damage disrupts normal blood flow, leading to reduced oxygen and nutrient delivery to tissues, and may result in atherosclerosis, thrombosis, or infection, ultimately causing gangrene.

Risk Factors

  • Poor glycemic control: Consistently high blood sugar levels increase risk.
  • Duration of diabetes: Longer duration of type 1 diabetes raises likelihood.
  • Hypertension: High blood pressure exacerbates vascular damage.
  • Dyslipidemia: Abnormal cholesterol or lipid levels contribute to circulatory issues.
  • Smoking: Contributes to vascular and circulatory damage.
  • Peripheral neuropathy: Nerve damage increases risk of injury and infection.
  • Foot ulcers or infections: Pre-existing wounds may progress to gangrene.

Symptoms

  • Severe pain or numbness in the affected limb.
  • Discoloration (black, blue, or purple) of the skin.
  • Foul-smelling discharge or tissue breakdown.
  • Coldness or absence of pulse in the extremity.
  • Systemic signs of infection (fever, chills, malaise).

Diagnosis

Diagnosis involves clinical evaluation of symptoms, physical examination of the affected area, and imaging studies (e.g., Doppler ultrasound, angiography) to assess blood flow. Laboratory tests may include blood glucose levels, hemoglobin A1c, and cultures to identify infection. Tissue biopsy or debridement may confirm gangrene.

Treatment Options

  • Glycemic control: Insulin therapy and blood sugar monitoring to prevent further vascular damage.
  • Antibiotics: For bacterial infections, often administered intravenously.
  • Surgical intervention: Debridement of necrotic tissue or amputation to remove gangrenous areas.
  • Revascularization: Procedures to restore blood flow (e.g., angioplasty, bypass surgery).
  • Wound care: dressings, negative pressure therapy, or hyperbaric oxygen to promote healing.

Prognosis and Follow-Up

Prognosis depends on the extent of tissue damage, timely treatment, and glycemic control. Early intervention improves outcomes, but severe cases may require amputation. Regular follow-up with a healthcare provider is essential to monitor for recurrence, manage diabetes, and address complications.

Complications

  • Amputation of the affected limb.
  • Sepsis or systemic infection.
  • Chronic pain or disability.
  • Increased risk of cardiovascular events.
  • Recurrence of gangrene in other areas.

Lifestyle & Prevention

  • Maintain strict glycemic control through insulin management and regular monitoring.
  • Perform daily foot inspections to detect early signs of injury or infection.
  • Wear proper footwear to prevent trauma.
  • Avoid smoking and manage hypertension/dyslipidemia.
  • Seek prompt care for foot ulcers or infections.

When to Seek Professional Help

  • Notice discoloration, pain, or numbness in the extremities.
  • Develop a foul-smelling wound or discharge.
  • Experience fever, chills, or signs of systemic infection.
  • Have uncontrolled blood sugar levels despite treatment.

Tips for Medical Coders

Document the presence of gangrene and its location (e.g., foot, toe) to support the E10.52 code. Include details of vascular impairment (e.g., angiopathy) and any associated infections or surgical interventions. Ensure documentation aligns with clinical findings to justify the specificity of this code.

Book a walkthrough

E10.52 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.